health
NHS-Galleri Reports Galleri Test Performance; Trial Endpoint Was Not Met
An analysis of the NHS-Galleri trial reports Galleri’s performance across three annual screening rounds, including falling episode sensitivity in later rounds. The trial’s primary endpoint—a reduction in stage III/IV cancer diagnoses—was not met.